Therapeutic potential of tyrosine kinase 2 in autoimmunity.

about

In vivo tumor surveillance by NK cells requires TYK2 but not TYK2 kinase activity IL-17A-producing CD8(+)T cells as therapeutic targets in autoimmunity.Influence of TYK2 in systemic sclerosis susceptibility: a new locus in the IL-12 pathway.

P2860

Q36107965-D38B6B2A-C7AA-4D5B-A18E-081179981B2A Q38328539-C69DD460-06A3-43FF-A340-3CC3B98EBAE7 Q52862671-24711E94-E579-48BB-97D9-BE7D06DE6B1B

P2860

Therapeutic potential of tyrosine kinase 2 in autoimmunity.

Item

http://www.wikidata.org/entity/Q38198086

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Therapeutic potential of tyrosine kinase 2 in autoimmunity.

@en

type

Item

label

Therapeutic potential of tyrosine kinase 2 in autoimmunity.

@en

prefLabel

Therapeutic potential of tyrosine kinase 2 in autoimmunity.

@en

P1476

Therapeutic potential of tyrosine kinase 2 in autoimmunity

@en

P2093

Dong-Qing Ye

http://www.w3.org/2001/XMLSchema#string

Hui Peng

http://www.w3.org/2001/XMLSchema#string

Wang-Dong Xu

http://www.w3.org/2001/XMLSchema#string

Xiao-Ke Yang

http://www.w3.org/2001/XMLSchema#string

Yan Liang

http://www.w3.org/2001/XMLSchema#string

Yan Zhu

http://www.w3.org/2001/XMLSchema#string

Yan-Yan Liu

http://www.w3.org/2001/XMLSchema#string

Yi Xia

http://www.w3.org/2001/XMLSchema#string

P2860

CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling

Janus kinases in immune cell signaling

Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus

Protein tyrosine phosphatase 1B negatively regulates macrophage development through CSF-1 signaling.

Tyk2 tyrosine kinase expression is required for the maintenance of mitochondrial respiration in primary pro-B lymphocytes

A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunity

Structural and thermodynamic characterization of the TYK2 and JAK3 kinase domains in complex with CP-690550 and CMP-6

A new regulatory switch in a JAK protein kinase

Enabling structure-based drug design of Tyk2 through co-crystallization with a stabilizing aminoindazole inhibitor

Daxx: death or survival protein?

P304

571-580

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728222.2014.892925

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hai-Feng Pan

P577

2014-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24654603

http://www.w3.org/2001/XMLSchema#string

Therapeutic potential of tyrosine kinase 2 in autoimmunity.

about

P2860

P2860

Therapeutic potential of tyrosine kinase 2 in autoimmunity.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698